account and target diseases, conditions, and care interventions that have a high-impact on national health expenditures and advance the incorporation of practical evidence into health care delivery in the national priorities for research and the research project agenda under paragraph (1). Such panel shall include members representing private and public payers in addition to the composition requirements described in subparagraph (B). . (e) Ensuring coverage for clinical trials under existing standard of care (1) Revision to definition of approved clinical trial in individual and group market (A) In general Subsection (d)(1) of the first section 2709 of the Public Health Service Act ( 42 U.S.C. 300gg–8 ) is amended by adding at the end the following new subparagraph: (D) The study or investigation is approved or funded (which may include funding through in-kind contributions) by the Patient-Centered Outcomes Research Institute established under section 1181 of the Social Security Act. . (B) Applicability date The amendment made by this paragraph shall apply with respect to plan years beginning on or after January 1, 2020. (2) Medicare coverage of routine costs associated with certain clinical trials (A) In general Section 1862(m)(2) of the Social Security Act ( 42 U.S.C. 1395y(m)(2) ) is amended, in the matter preceding subparagraph (A), by inserting (including a trial funded by the Patient-Centered Outcomes Research Institute established under section 1181) after means a trial . (B) Effective date The amendment made by this subparagraph shall apply with respect to items and services furnished on or after the date of the enactment of this Act. (f) Additions to annual reports by the Institute Subsection (d)(10)(A) of such section 1181 is amended— (1) by inserting , including narrative statements of funding announcements of the Institute, after paragraph (1)(A)